Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Arcutis Biotherapeutics Inc

ARQT
Current price
1.99 USD +0.14 USD (+7.57%)
Last closed 1.84 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 191 595 648 USD
Yield for 12 month -88.64 %
Week
Month
Year
ARQT
21.11.2021 - 28.11.2021

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical formulation of ivarmacitinib designed to reach deeper into the skin in order to treat alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California. Address: 3027 Townsgate Road, Westlake Village, CA, United States, 91361

Analytics

WallStreet Target Price

11.17 USD

P/E ratio

Dividend Yield

Current Year

+3 686 000 USD

Last Year

Current Quarter

+38 109 000 USD

Last Quarter

+5 190 000 USD

Current Year

+2 932 000 USD

Last Year

Current Quarter

+36 927 000 USD

Last Quarter

+4 414 000 USD

Key Figures ARQT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -246 872 992 USD
Operating Margin TTM -96.84 %
PE Ratio
Return On Assets TTM -38.72 %
PEG Ratio
Return On Equity TTM -168.74 %
Wall Street Target Price 11.17 USD
Revenue TTM 49 041 000 USD
Book Value 0.76 USD
Revenue Per Share TTM 0.8 USD
Dividend Share
Quarterly Revenue Growth YOY 5156.4 %
Dividend Yield
Gross Profit TTM 2 932 000 USD
Earnings Share -4.33 USD
Diluted Eps TTM -4.33 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ARQT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ARQT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ARQT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1017.8534
Price Sales TTM 1385.7922
Enterprise Value EBITDA -2.4478
Price Book MRQ 3.742

Financials ARQT

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ARQT

For 52 weeks

1.77 USD 18.19 USD
50 Day MA 3.56 USD
Shares Short Prior Month 14 055 401
200 Day MA 9.15 USD
Short Ratio 5.08
Shares Short 17 067 798
Short Percent 22.84 %